Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
Clinical trial NCT01635764 · COMPLETED
Trial details
- NCT number
- NCT01635764
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2016-08-01
- Enrollment
- 508
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.